P1070: NAVITOCLAX MONOTHERAPY IN PATIENTS WITH MYELOFIBROSIS PREVIOUSLY TREATED WITH JAK-2 INHIBITORS: SAFETY AND TOLERABILITY. (23rd June 2022) - Pullarkat, V.; Cruz-Chacon, A.; Gangatharan, S.; Melnyk, A.; Palumbo, G. A.; Bellini, M.; Tantravahi, S. K.; Qin, Q.; Potluri, J.; Vachhani, P.